Maccura completes sale of controlling subsidiary stake

Maccura Biotechnology announced today the completion of the share transfer and industrial and commercial registration for its controlling subsidiary, Shandong Maccura Biotechnology Co., Ltd. (Shandong Maccura). The transfer, which involved 51% of Shandong Maccura's equity, was approved on June 11, 2025, during the sixth board of directors' fourth meeting and the sixth supervisory board's fourth meeting. The transaction was valued at 17,412,879 yuan, with the shares transferred to Mr. Han Siguang.

Shandong Maccura has successfully updated its industrial and commercial registration and obtained a new business license from the market supervision and administration bureau. Key details from the new license indicate Shandong Maccura is now a limited liability company (wholly owned by natural persons). Mr. Han Siguang is listed as the legal representative.

The subsidiary, established on October 10, 2017, has a registered capital of 10,000,000 yuan. Its business scope includes biotechnology research, technical consulting, medical equipment leasing and maintenance, and various medical device wholesale and retail activities.